Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00308139
What this trial is testing

Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 303
Early research (Phase 1)Study completedNCT06636877
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Who this might be right for
Essential HypertensionType 2 Diabetes
Boryung Pharmaceutical Co., Ltd 52
Early research (Phase 1)Active Not RecruitingNCT07160257
What this trial is testing

Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Amgen 56
Early research (Phase 1)Study completedNCT03444467
What this trial is testing

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 36
Not applicableLooking for participantsNCT07260110
What this trial is testing

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Who this might be right for
Type 1 Diabetes
Sanofi 550
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Early research (Phase 1)Study completedNCT03341013
What this trial is testing

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 24
Large-scale testing (Phase 3)Study completedNCT01512108
What this trial is testing

Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 363
Testing effectiveness (Phase 2)Ended earlyNCT06007508
What this trial is testing

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

Who this might be right for
DKA
HealthPartners Institute 8
Early research (Phase 1)UnknownNCT01201278
What this trial is testing

PK/PD Study of Intranasal Insulin in Type I Diabetes

Who this might be right for
Type 1 Diabetes
Hompesch, Marcus, M.D. 20
Not applicableEnded earlyNCT00870831
What this trial is testing

Islet Function and Clinical Analyses of Transplant Recipients

Who this might be right for
Type One Diabetes Mellitus
Washington University School of Medicine 8
Not applicableStudy completedNCT01503112
What this trial is testing

Predicting Response to Incretin Based Agents in Type 2 Diabetes

Who this might be right for
Type2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 957
Not applicableStudy completedNCT02103595
What this trial is testing

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Who this might be right for
Diabetes Mellitus Type 2, Diabetes Mellitus Type 1
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT03439072
What this trial is testing

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Who this might be right for
Insulin HypoglycemiaType 1 Diabetes MellitusSevere Hypoglycemia
Xeris Pharmaceuticals 81
Early research (Phase 1)Study completedNCT02206607
What this trial is testing

Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 39
Not applicableStudy completedNCT05683392
What this trial is testing

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Tandem Diabetes Care, Inc. 72
Early research (Phase 1)Ended earlyNCT01488877
What this trial is testing

Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Nephropathy
Pfizer 6
Not applicableStudy completedNCT01490112
What this trial is testing

Surveillance Study of NovoRapid® for New Drug Re-examination

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,239
Early research (Phase 1)Study completedNCT02115347
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)

Who this might be right for
Type 2 Diabetes MellitusHepatic Impairment
Merck Sharp & Dohme LLC 16
Not applicableActive Not RecruitingNCT03860558
What this trial is testing

Impact of Metabolic Health on Sperm Epigenetic Marks in Humans

Who this might be right for
OverweightType 2 Diabetes MellitusType 1 Diabetes Mellitus
Joslin Diabetes Center 40
Next Page